Opinion
Video
Author(s):
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Stay up to date on cancer updates, research and education
How Can We Stand Up to Cancer as Patients?
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
DNA Test Outperforms PET/CT Scans When Detecting Lymphoma
The Treatment Journey of a Patient with CLL
Immunoglobulin Replacement Not Associated With Fewer Infections in CLL
Men Can Get Breast Cancer Too